Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Daily Rapid Lateral Flow COVID-19 Tests for Traced Contacts for Five Days Could Replace Requirement to Quarantine, Reveals Study

By LabMedica International staff writers
Posted on 25 Jan 2021
Additional testing with either a PCR or lateral flow antigen (LFA) test could potentially reduce the quarantine time of contacts of a confirmed case to seven days from the WHO recommended 14-day quarantine period without raising the risk of onward transmission, according to a new modeling study.

Researchers at the London School of Hygiene & Tropical Medicine (LSHTM; London, UK) conducted the study using mathematical modeling to estimate the effect of different quarantine and testing strategies on reducing onward transmission from traced secondary infections. More...
The team simulated the levels of virus an infected person would be likely to produce at each stage of infection, alongside timing of symptom onset, test sensitivity and tracing and testing timings. The team estimate that completing the full 14-day recommended quarantine period for contacts of COVID-19 cases could prevent 59% of onward virus transmission. A similar proportion of onward transmission could potentially be prevented with only seven days of quarantine if a PCR or LFA test is performed on the final day of quarantine and people who receive a negative result are released.

The study estimates that the quarantine period could be replaced if traced contacts are required to take a daily LFA test for five days and those who do not receive any positive results are released, with 50% of onward virus transmission predicted to be prevented. If people adhere perfectly to self-isolation for the recommended 14 days after a positive test, and their close contacts taking a daily LFA test for five days and are then released on the final day if all tests are negative, the model estimates 80% of onward virus transmission could potentially be averted. Notably, the model is based on the assumption that the LFA test works at the higher level of sensitivity, detecting on average 76.8% of cases that tested positive in a PCR test.

“Our findings suggest that introducing testing of contacts in contact tracing may allow for a large reduction in the duration of quarantine,” said Billy Quilty, joint-lead author and Research Assistant at LSHTM. “Daily rapid tests for at least five days may allow for the quarantine requirement to be removed entirely, with self-isolation required only upon the onset of symptoms or a positive rapid test result. This strategy may allow for critical essential workers to continue working if exposed but not infected.”

Related Links:
London School of Hygiene & Tropical Medicine (LSHTM)


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Portable Electronic Pipette
Mini 96
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.